Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Probi is a global B2B company focused on biotics/probiotic solutions. It originated from Lund University in Sweden in 1991 and is now part of Symrise Group. The text indicates that its business spans R&D, clinical research, strain development, manufacturing, documentation support, and global partnerships, with presence in more than 40 markets and over 350 global patents. It is worth noting that probi.com is not a typical SaaS or enterprise software website, but rather a supplier of nutrition, health, and probiotic ingredients/solutions.
Its core assets include proprietary strains such as LP299V®, a dual-strain formulation of LP299V and LpGOS42, and health solutions targeting digestion, immunity, metabolism, women’s health, children’s health, oral health, healthy aging, mental well-being, and sports nutrition. The website also provides a Product guide to match health needs with product options. On the manufacturing side, Probi emphasizes capabilities from single colonies to finished bottled products under customers’ own labels, covering applications such as dietary supplements, functional foods and beverages, pet probiotics, probiotic spores, and postbiotics.
The crawled text does not disclose public plans, unit pricing, a free version, or trial information. The business appears closer to project-based B2B collaboration, ingredient supply, licensing, or co-development. From a SaaS perspective, there is no visible information on third-party system integrations, team permissions, cloud deployment/self-hosting, APIs, or developer documentation. In terms of data security, only the event booking form mentions consent for Probi to store personal data and comply with its Privacy Notice; no more specific compliance certifications are shown.
Its strengths are a relatively complete research and industrial supply-chain capability, strong clinical research and patent reserves, and support for global market partnerships and private-label manufacturing. Its new clinical study used a randomized, placebo-controlled design and showed statistically significant improvements in bowel regularity, stool characteristics, and digestive comfort among healthy adults with occasional constipation. The limitations are that the website focuses more on brand and scientific presentation, while lacking details on purchasing thresholds, pricing, delivery timelines, and quality/compliance specifics. If assessed from an enterprise software procurement perspective, key IT-related information is largely missing.
It is best suited for nutrition and health brands, functional food and beverage companies, dietary supplement companies, pet health brands, and formulation teams looking to introduce clinically validated strains. The text mentions that Probi will attend HNC Expo 2026 in Shanghai and share a booth with distributor CNP, indicating attention to the China and broader Asian markets. The text does not specify access, payment, or contract pathways for Mainland China, so network accessibility is rated as unknown. Alternatives may include probiotic solution providers such as Chr. Hansen, Lallemand, IFF Health, and BLIS.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on probi.com official site.
probi.com is an Sweden SaaS provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach probi.com directly.